Nebenwirkungen · Signifor
Signifor 0.3 mg solution for injection Signifor 0.6 mg solution for injection Signifor 0.9 mg solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-213432 · Präparat HOS-155106
System Organ Very common Common Uncommon Not known Class Blood and Anaemia lymphatic system disorders Endocrine Adrenal disorders insufficiency Metabolism and Hyperglycaemia, Decreased Diabetic nutrition diabetes mellitus appetite, type 2 ketoacidosis disorders diabetes mellitus, glucose tolerance impaired Nervous system Headache, disorders dizziness Cardiac Sinus disorders bradycardia, QT prolongation Vascular Hypotension disorders Gastrointestinal Diarrhoea, Vomiting, Steatorrhea disorders abdominal pain, abdominal pain Faeces nausea upper discoloured Hepatobiliary Cholelithiasis Cholecystitis *, disorders cholestasis Skin and Alopecia, pruritus subcutaneous tissue disorders Musculoskeletal Myalgia, and connective arthralgia tissue disorders General Injection site disorders and reaction, fatigue administration site conditions Investigations Glycosylated Gamma haemoglobin glutamyltransfera increased se increased, alanine aminotransferase increased, aspartate aminotransferase increased, lipase increased, blood glucose increased, blood amylase increased, prothrombin time prolonged * Cholecystitis includes cholecystitis acute
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-12-18T10:26:00Z · SHA-256 8d39a4369995f88230d9c38d5acd5d8dc8ac03b6669b211c0130be10866c5ae6 · Passage 50a6daab58178f812c0d25d15026990c3f82d7be0eec6706f5cde2797df802ce · Zeichen 2164–4782 im Abschnitt